Company Filing History:
3 out of 31 
1 out of 832,843 Years Active: 2002-2011
Title: Paul Erickson Friedrich: Innovator in HIV Research
Introduction
Paul Erickson Friedrich is a notable inventor based in Apex, NC (US), recognized for his contributions to the field of HIV research. He holds a total of four patents, showcasing his commitment to advancing medical science and improving treatment options for patients.
Latest Patents
Friedrich's latest patents focus on HIV fusion inhibitor peptides with improved biological properties. These patents provide innovative HIV fusion inhibitor peptides characterized by specific amino acid sequences, including SEQ ID NO:9 through SEQ ID NO:15. Additionally, the patents describe pharmaceutical compositions that comprise these peptides along with pharmaceutically acceptable carriers and macromolecular carriers. The methods of treatment provided by these compositions aim to enhance therapeutic outcomes for individuals affected by HIV.
Career Highlights
Throughout his career, Friedrich has made significant strides in the pharmaceutical industry. He has worked with Trimeris, Inc., where he contributed to the development of groundbreaking treatments for HIV. His work has been instrumental in shaping the landscape of HIV research and therapy.
Collaborations
Friedrich has collaborated with notable colleagues, including Brian L Bray and Marc W Andersen. These partnerships have fostered innovation and have been crucial in advancing research initiatives in the field.
Conclusion
Paul Erickson Friedrich's work in HIV research exemplifies the impact of innovation in medicine. His patents and collaborations reflect a dedication to improving health outcomes for those living with HIV.